Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Weight Loss in Cancer Survivors
NCT02431676Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- May 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in breast cancer, prostate cancer (PCa), lung cancer, colon cancer, melanoma, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started May 2015; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
breast cancerprostate cancer (PCa)lung cancercolon cancermelanoma
Beyond the preview
Go deeper on NCT02431676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431676.